Research Grade Lintuzumab
Product Sizes
1 mg
£506.00
DHD37502-1MG
5 mg
£1169.00
DHD37502-5MG
25 mg
£1641.00
DHD37502-25MG
About this Product
- SKU:
- DHD37502
- Additional Names:
- 225Ac-lintuzumab, HuM195, SGN-33, SMART M195, HuM195, CAS: 166089-32-3
- Buffer:
- 0.01M PBS, pH 7.4.
- translate.label.attr.clone:
- Lintuzumab
- Clonality:
- Recombinant Monoclonal
- Concentration:
- 1.39 mg/ml
- Extra Details:
- Lintuzumab is a humanized monoclonal antibody, HuM195, that targets the cell surface antigen CD33 that is expressed on the vast majority of acute myeloid leukemia (AML) cells. [225 Ac]Ac-lintuzumab clinical trials were discussed in detail in reference . Lintuzumab is under investigation in clinical trial NCT00016159 (Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia).
- Host:
- Human
- Immunogen:
- Myeloid cell surface antigen CD33, Sialic acid-binding Ig-like lectin 3, Siglec-3, CD33, gp67, SIGLEC3
- Isotype:
- IgG1, kappa
- Physical State:
- Liquid
- Purity:
- >95%
- Purification:
- Protein A/G purified from cell culture supernatant.
- Reactivities:
- Human
- Shipping Conditions:
- Blue Ice
- Source:
- XtenCHO
- Storage Conditions:
- -20[o]C Avoid freeze/thaw cycles., 2-8[o]C Avoid freeze/thaw cycles., -70[o]C Avoid freeze/thaw cycles.
- Supplier:
- AntibodySystem
- Type:
- Antibody: Recombinant Antibodies
- Manufacturer's Data Sheet:156.html
